Concerns on methodological assumptions in the health economic Evaluation of return-to-work interventions [0.03%]
回归工作干预措施的卫生经济学评价中的假设问题不容忽视
Afschin Gandjour
Afschin Gandjour
This Key Paper Evaluation examines a recent modeling study of return-to-work (RTW) interventions comparing inpatient multimodal occupational rehabilitation (I-MORE) with outpatient Acceptance and Commitment Therapy (ACT). The authors link a...
Impact of an expanded male catch-up HPV vaccination program on the clinical and economic burden of HPV-associated diseases in Denmark: a modeling study [0.03%]
丹麦男性人乳头瘤病毒(HPV)疫苗补种计划对临床和经济负担的影响：建模研究
Emilie Theisen Honore,Thomas Le Fevre,Andrew Pavelyev et al.
Emilie Theisen Honore et al.
Background: Denmark's publicly funded routine HPV vaccination program has included boys born from 2005 onward, leaving earlier birth cohorts of young men potentially unprotected. ...
Economic evaluation of percutaneous patent foramen ovale closure versus medical therapy in patients with a cryptogenic stroke: a systematic review [0.03%]
卵圆孔未闭封堵术与卒中后医疗治疗的经济评估：系统性综述
Aziz Rezapour,Mohsen Rezaeian,Saeed Bagheri Faradonbeh et al.
Aziz Rezapour et al.
Introduction: The risk of recurrent ischemic strokes in young to middle-aged patients who have experienced a recent cryptogenic ischemic stroke is reduced by percutaneous closure of a patent foramen ovale (PFO) in compari...
Cost-effectiveness analysis of rezivertinib and gefitinib in patients with EGFR-mutated advanced non-small cell lung cancer [0.03%]
瑞替普坦和吉非替尼治疗EGFR突变的晚期非小细胞肺癌的成本效益分析
Conghui Kou,Huina Wu,Lihui Liu et al.
Conghui Kou et al.
Background: Epidermal growth factor receptor (EGFR) mutations represent the primary driver alterations in advanced non-small cell lung cancer (NSCLC). Rezivertinib has emerged as a promising targeted therapy for EGFR-muta...
Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States [0.03%]
在美国接受司美格鲁肽治疗的多病共存的超重或肥胖患者的真实世界医疗资源利用和医疗费用
Prachi Arora,Firas Dabbous,Sariya Udayachalerm et al.
Prachi Arora et al.
Background: Patients with overweight or obesity (OW/OB) are at increased risk for multimorbidity (≥2 obesity-related complications [ORCs]) and accompanying increases in mortality and excess costs. ...
Cost-effectiveness analysis of artificial intelligence (AI) for response prediction of neoadjuvant radio(chemo)therapy in locally advanced rectal cancer (LARC) in the Netherlands [0.03%]
人工智能预测新辅助放（化）疗后局部晚期直肠癌（LARC）反应的 cost-effectiveness 分析
L Maas,C Contreras-Meca,S Ghezzo et al.
L Maas et al.
Background: Given the potential of artificial intelligence (AI) and the increasing importance of understanding AI's economic impact, this study aims to provide insights into the potential cost-effectiveness of an AI tool ...
How do we approach integrating digital endpoint studies into Health technology assessment? [0.03%]
如何在卫生技术评估中纳入数字化终端研究？
Vijay Kumar Chattu,Anthony Scaffeo,Sujatha Alla et al.
Vijay Kumar Chattu et al.
Introduction: The integration of digital endpoints into Health Technology Assessment (HTA) marks a significant advancement in modern healthcare evaluation, especially in the context of post-pandemic growth in telehealth a...
Cost of rimegepant and lasmiditan associated adverse events, for acute treatment in migraine in Spain [0.03%]
西班牙急性治疗偏头痛的rimegepant和lasmiditan相关不良事件的成本
Sonia Santos Lasaosa,Beatriz Armada,Carlota Moya-Alarcón et al.
Sonia Santos Lasaosa et al.
Objective: To compare the cost of adverse events (AEs) associated with the acute treatment with rimegepant (RIM) versus lasmiditan (LAS) for migraine in Spain. ...
Cost-utility of pre-emptive plerixafor versus rescue plerixafor in the mobilization of hematopoietic stem cells in multiple myeloma [0.03%]
在多发性骨髓瘤中预防使用普乐西福动员造血干细胞的效用成本分析与补救使用相比
Tallys Feldens,Roselene Mesquita Augusto Passos,Juliana de Oliveira Martins et al.
Tallys Feldens et al.
Background: Multiple myeloma (MM) is a hematologic cancer withrising incidence worldwide. Autologous stem cell transplantation(ASCT) is a key treatment for eligible patients, but mobilizationfailure remains a major obstac...
The pharmaceutical market: a transdisciplinary description of concepts and their implications [0.03%]
药学市场：一种跨学科的概念描述及其影响
André Soares Motta-Santos,Kenya Valéria Micaela de Souza Noronha,Leonardo Costa Ribeiro et al.
André Soares Motta-Santos et al.
Introduction: The pharmaceutical industry has delivered innovative therapies that substantially improved health outcomes. However, concerns persist regarding high drug prices and delays in the entry of competitors. This a...